The HBOT market splits into two camps. Real medicine on one side. Cash-pay wellness on the other.
The UHMS maintains the approved list, and CMS mirrors it under NCD 20.29. If your condition isn't on the list, insurance won't pay.
This guide ranks ten UHMS-approved uses by evidence and urgency. Each entry covers the indication, evidence, protocol, and Medicare status.
At a Glance: 10 UHMS-Approved HBOT Conditions
| Rank | Condition | UHMS Status | Insurance Coverage | Verdict |
|---|---|---|---|---|
| 1 | Decompression Sickness | Approved | Medicare covered | Best-evidenced HBOT use |
| 2 | Carbon Monoxide Poisoning | Approved | Medicare covered | Strongest neuro outcome data |
| 3 | Gas Gangrene | Approved | Medicare covered | Life-saving adjunct |
| 4 | Crush Injury & Compartment Syndrome | Approved | Medicare covered | Limb salvage standard |
| 5 | Diabetic Foot Ulcers (Wagner 3+) | Approved | Medicare covered | Most-billed outpatient use |
| 6 | Delayed Radiation Injury | Approved | Medicare covered | Marx protocol gold standard |
| 7 | Compromised Grafts & Flaps | Approved | Medicare covered | Best surgical rescue use |
| 8 | Severe Anemia | Approved | Medicare covered | Religious-objection bridge |
| 9 | Intracranial Abscess | Approved | Medicare covered | Best CNS infection adjunct |
| 10 | Necrotizing Soft Tissue Infections | Approved | Medicare covered | Sepsis-mortality reducer |
1. Decompression Sickness — Diving Emergency Standard (Verdict: Best-evidenced HBOT use)
Decompression sickness is the original HBOT use. Nitrogen bubbles form in tissues during ascent, and recompression dissolves them. The US Navy Treatment Table 6, current per 2024 DAN guidance, runs at 2.82 ATA for five hours.
Evidence is the strongest of any HBOT use. The UHMS lists it as Category 1, with outcomes data spanning 70 years. A 2024 retrospective in Diving Hyperbaric Medicine showed faster recompression reduces residual symptoms.
Medicare covers DCS under NCD 20.29 (CMS, current 2026). ICD-10 billing uses T70.3XXA (caisson disease, initial encounter).
Most cases route to multiplace chambers because monoplace units can't accommodate an inside attendant.
2. Carbon Monoxide Poisoning — Cognitive Sequelae Prevention (Verdict: Strongest neuro outcome data)
The landmark Weaver trial in NEJM 2002 cemented HBOT for acute CO poisoning. Three sessions at 3.0 ATA in 24 hours cut six-week cognitive harm from 46% to 25%. The benefit held at 12 months.
Protocol is three HBOT sessions in the first day, the first at 3.0 ATA for 60 minutes, then two at 2.0 ATA. A 2019 meta-analysis in Medicine (PMC) confirmed the mortality and neurologic-sequelae reduction across pooled trials.
CMS covers acute CO poisoning under NCD 20.29. Bill with T58.01XA (toxic effect of CO from motor vehicle exhaust, initial).
The 2018 Undersea Hyperbaric Med practice guideline sets carboxyhemoglobin >25%, loss of consciousness, or any neurologic sign as treatment threshold.
3. Gas Gangrene (Clostridial Myonecrosis) — Adjunct to Surgery and Antibiotics (Verdict: Life-saving adjunct)
Clostridial myonecrosis kills tissue fast. HBOT at 3.0 ATA halts alpha-toxin output by Clostridium perfringens and raises tissue oxygen tension to a lethal range for the bug. It's never standalone — surgery and antibiotics come first.
The UHMS lists gas gangrene as Category 1. Typical protocol runs three sessions in the first 24 hours at 3.0 ATA for 90 minutes, then twice daily until the patient stabilizes. A 2024 institutional series in PMC reported significant mortality reduction when HBOT was added within 24 hours of diagnosis.
Medicare covers gas gangrene under NCD 20.29. Bill with A48.0 (gas gangrene).
Multiplace chambers handle these patients because they're often intubated and unstable on pressors.
4. Crush Injury & Compartment Syndrome — Limb-Salvage Standard (Verdict: Best evidence for traumatic limb threat)
Crush injuries with reperfusion damage benefit from HBOT's ability to oxygenate starved tissue and curb neutrophil-driven harm. Protocol runs 2.0-2.5 ATA, three sessions on day one, then twice daily for 48 hours, tapering over a week.
A 2023 systematic review (PMC) found HBOT-adjunct treatment improved wound healing and reduced major amputations versus standard care alone. The UHMS lists crush injury, compartment syndrome, and acute traumatic ischemia together as a single Category 1 indication.
CMS covers acute traumatic peripheral ischemia under NCD 20.29.
ICD-10 billing uses T79.6XXA for traumatic ischemia of muscle. Most patients route through Level 1 trauma centers with attached hyperbaric units.
5. Diabetic Foot Ulcers (Wagner Grade 3+) — Most-Billed Outpatient Use (Verdict: Largest commercial use case)
Diabetic foot ulcers drive more outpatient HBOT billing than any other indication. CMS sets strict criteria. The patient must have Type 1 or Type 2 diabetes, a Wagner Grade 3+ wound, and failed 30 days of standard wound care per NCD 20.29.
Protocol is 90-minute sessions at 2.0-2.5 ATA, five days a week, for 20-40 sessions. A 2024 UHMS-supported registry analysis (PMC) showed wound closure rates roughly double those of standard care alone in Wagner Grade 3 ulcers.
Billing pairs CPT 99183 (physician supervision) with HCPCS G0277 (facility, per Medical Billers and Coders 2026 guide).
ICD-10 uses E11.621 for Type 2 diabetes with foot ulcer, paired with the wound's L97.4 code.
Medicare caps daily billing at five units, or 150 minutes.
6. Delayed Radiation Injury (Soft Tissue & Bone) — Marx Protocol Standard (Verdict: Best-evidenced delayed indication)
Radiation damages tissue blood vessels for years. HBOT triggers new vessel growth in irradiated tissue, the only known fix in Marx's rabbit jaw model per the 2024 StatPearls review.
The Marx Protocol runs 90-minute sessions at 2.4 ATA. Pre-surgical patients get 20-30 sessions before extraction or flap surgery, then 10 sessions after. A 2020 institutional experience in PMC reported osteoradionecrosis healing rates above 80% with the full Marx course.
CMS covers delayed radiation injury under NCD 20.29.
ICD-10 billing uses T66.XXXA for radiation effects. This is the second-most-billed outpatient indication after diabetic ulcers.
7. Compromised Skin Grafts & Flaps — Surgical Rescue Standard (Verdict: Best for failing reconstruction)
When a skin graft or surgical flap shows early signs of failure, HBOT can rescue it. Pressurized oxygen reaches ischemic tissue that the marginal blood supply can't, buying time for revascularization. Timing matters — within 48 hours of the failure signs.
Protocol is twice-daily sessions at 2.0-2.5 ATA for 90 minutes, continuing for 10-20 sessions or until the graft declares. The UHMS lists compromised grafts and flaps as Category 1. A 2024 review (UHC provider PDF) noted improved survival of compromised tissue versus standard wound care.
CMS covers compromised flaps and grafts under NCD 20.29.
ICD-10 billing uses T86.821 for skin graft rejection. Plastic and reconstructive surgery centers with attached hyperbaric units are the typical site of care.
8. Severe Anemia (Exceptional Blood Loss) — Religious-Objection Bridge (Verdict: Best for transfusion-ineligible patients)
Severe anemia is the rare HBOT indication where the patient can't accept the alternative. Jehovah's Witnesses and patients with rare blood-incompatibility cases use HBOT to keep dissolved oxygen high enough for tissue survival until red cell mass can recover. See the severe anemia evidence atlas for the full study-by-study evidence breakdown.
Protocol runs 90-minute sessions at 2.0-2.5 ATA, two to three times daily, until hemoglobin recovers. The UHMS lists severe anemia from exceptional blood loss as Category 1. Use cases are rare but well-documented in trauma and hemato-oncology literature.
CMS covers exceptional blood loss anemia under NCD 20.29. Bill with D62 (acute posthemorrhagic anemia). Tertiary academic medical centers with multiplace chambers handle the bulk of these cases because they're often critically ill and need bedside ICU care.
9. Intracranial Abscess — Best CNS Infection Adjunct (Verdict: Best refractory-infection rescue)
Brain abscesses from mixed aerobic-anaerobic infections respond to HBOT as an adjunct. Pressurized oxygen reaches abscess pockets where antibiotics struggle. High tissue oxygen tension also kills anaerobes. See the intracranial abscess evidence atlas for the full study-by-study evidence breakdown.
Protocol runs daily sessions at 2.0-2.4 ATA for 60-90 minutes, continuing for 20-30 sessions. The UHMS lists intracranial abscess as Category 1. A 2024 UHC provider policy update maintained coverage based on case series showing reduced mortality versus antibiotics alone.
CMS covers intracranial abscess under NCD 20.29. Bill with G06.0 (intracranial abscess and granuloma).
Multiplace chambers with neuro-ICU integration are the standard site because patients often need ventricular drains during therapy.
10. Necrotizing Soft Tissue Infections — Sepsis-Mortality Reducer (Verdict: Best survival benefit for NSTI)
Necrotizing fasciitis kills 25-30% of patients despite surgery and antibiotics. HBOT adjunct therapy improves survival by halting anaerobe growth and boosting neutrophil killing in low-oxygen wound margins.
Protocol runs 90-minute sessions at 2.0-3.0 ATA, two to three times daily for the first 48-72 hours, then daily until stabilization. A 2023 systematic review (PMC) found pooled mortality reductions when HBOT was added within 24 hours of surgical debridement.
CMS covers necrotizing soft tissue infections under NCD 20.29.
ICD-10 billing uses M72.6 for necrotizing fasciitis. Bill at the multiplace facility rate when an inside attendant manages the patient during sessions.
How We Ranked
We rank HBOT centers and chambers on three primary signals — never one in isolation:
- Verifiable clinical attributes: chamber type (hard-shell vs soft-shell), UHMS accreditation status, ATA pressure capability, treatment-staff credentialing, and whether the center accepts Medicare/insurance. Cross-checked against the UHMS Hyperbaric Facility Accreditation list and FDA 510(k) device clearances.
- Patient-reported safety + outcomes data: Google reviews from the past 24 months, Reddit r/Hyperbaric + r/longCOVID discussion threads, and any documented safety incidents from state DOH records.
- Editorial verification: phone calls to each center asking the same five questions (chamber pressure capability, accepted indications, insurance billing, session length, accreditation status). We log responses, including non-responsive practices.
What we never accept: paid placement, "verified-listing" upgrade fees in exchange for higher rankings, manufacturer relationships that influence chamber-type recommendations. Disclosure: we use affiliate links to Amazon and select home-chamber retailers — these never modify which products rank where.
Update cadence: monthly review for chambers, quarterly for clinics. Last-updated date at the top of every article. Report inaccuracies to research@hyperbaricfinder.com — corrections shipped within 72 hours.
Frequently Asked Questions
Q: Does insurance actually cover HBOT for these conditions? A: Medicare covers 13 of the 14 UHMS-approved indications under NCD 20.29, and most commercial insurers follow suit. The exceptions are idiopathic sudden sensorineural hearing loss (variable coverage) and acute thermal burns (coverage requires meeting specific Total Body Surface Area criteria). Off-label conditions like long COVID, autism, and mild TBI are not covered by any major insurer in 2026.
Q: What's the difference between an FDA-approved condition and an off-label use? A: An FDA-cleared chamber is approved to treat any condition the prescribing physician deems appropriate, but insurance reimbursement only follows the UHMS-approved list mirrored in NCD 20.29. Off-label use is legal but cash-pay. Many wellness clinics offer mild HBOT at 1.3 ATA for off-label conditions, which sits outside the FDA's clinical clearance pathway entirely.
Q: Are there real side effects from approved HBOT? A: Yes. Barotrauma to the ears affects up to 15% of patients, oxygen toxicity seizures occur in roughly 1 in 10,000 sessions, and temporary myopia (nearsightedness) develops in about 20% of patients on extended courses. Pneumothorax is a known but rare risk. Pre-screening for ear surgery history, untreated seizure disorder, and certain lung conditions is standard.
Q: What if HBOT isn't an option — are there alternatives? A: For chronic wounds, negative pressure wound therapy (wound vacs), bioengineered skin substitutes, and topical growth factors are standard alternatives. For CO poisoning, normobaric 100% oxygen via non-rebreather is the second-line standard. For decompression sickness, no real substitute exists — recompression is the only definitive treatment.
Q: Where do I receive HBOT for an approved indication? A: Hospital-based wound centers handle most diabetic ulcer, radiation injury, and graft cases. Level 1 trauma centers handle crush injuries and necrotizing infections. Academic medical centers with multiplace chambers handle decompression sickness, gas gangrene, and severe anemia. Standalone outpatient wound centers cover the bulk of Wagner Grade 3+ diabetic ulcer volume.
Bottom Line
Only the 14 UHMS-approved indications get insurance reimbursement under NCD 20.29. Decompression sickness, CO poisoning, and gas gangrene carry the strongest acute-care evidence. Diabetic ulcers and radiation injury drive the bulk of outpatient billing volume.
For chamber selection, our Top 10 HBOT Chamber Types Compared (2026) breaks down the hardware behind these protocols. For coverage specifics, see HBOT Insurance Coverage Across the 14 Indications. For the mild HBOT distinction, read Mild HBOT vs Hospital-Grade HBOT.
-- The HBOT Finder Team